Business Daily.
.
A+ R A-

Cellanyx Diagnostics Announces Expanded Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer

E-mail Print PDF
BEVERLY, Mass.--(BUSINESS WIRE)--Cellanyx Diagnostics reports expanded clinical data with novel live cell phenotypic biomarker test for prostate cancer risk stratification at American Urological Assn annual meeting

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media